Rhodanine derivative and preparation method thereof

A technology of derivatives and anti-tumor drugs, applied in the field of rhodanine derivatives and its preparation, can solve the problems of cytotoxicity, short half-life of sodium hydrosulfide, DNA damage of human lung fibroblasts, etc., and achieve good inhibitory effect and strong activity Effect

Inactive Publication Date: 2013-04-03
SUZHOU UNIV
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Sodium hydrosulfide, an exogenous hydrogen sulfide donor, causes DNA damage in human lung fibroblasts by inducing the levels of downstream apoptotic proteins such as p21, Bax and cytochrome c, but not upregulating the levels of the anti-apoptotic prot...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rhodanine derivative and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] (1) Add 0.494g, 2.0mmol of 2-[-4-oxo-2-thio-thiazolidin-3-yl]-4-methylpentanoic acid, 0.368g, 2.0mmol of p-bromobenzaldehyde and Add 0.313g and 4.1mmol of ammonium acetate to 20mL of toluene, heat and reflux for 1h, evaporate the solvent under reduced pressure, and perform column chromatography with eluent petroleum ether and ethyl acetate at a volume ratio of 4:1 to obtain a light yellow solid, the product The rate is 75.9%, and the melting point is 148.5~152.0°C. The hydrogen spectrum of the product Z-2-[5-(4-bromobenzylidene)-4-oxo-2-thio-thiazolidin-3-yl]-4-methylpentanoic acid 1 H NMR (400MHz, CDCl 3 ) δ: 0.94(d, 3H, J=6.6Hz, CH 3 ), 0.98(d, 3H, J=6.5Hz, CH 3 ), 1.48~1.61(m, 1H, CH), 2.08~ 2.16(m, 1H, CH 2 ), 2.25~2.32(m, 1H, CH 2 ), 5.79~5.80(m, 1H, CH), 7.35(d, 2H, J=8.4Hz, ArH), 7.62(d, 2H, J=8.0Hz,ArH), 7.63(s, 1H, =CH) .

[0020] (2) 495.576mg, 1.2mmol of Z-2-[5-(4-bromobenzylidene)-4-oxo-2-thio-thiazolidin-3-yl]-4-methylpentanoic acid , 299mg, 1.5mmol...

Embodiment 2

[0023] (1) Using p-bromobenzaldehyde and 2-(4-oxo-2-thio-thiazolidin-3-yl)-3-methylbutyric acid as raw materials, the preparation process is the same as step (1) of Example 1, A light yellow solid was obtained with a yield of 78.4% and a melting point of 157.9~160.1°C. The hydrogen spectrum of the product Z-2-[5-(4-bromobenzylidene)-4-oxo-2-thio-thiazolidin-3-yl]-3-methylbutanoic acid 1 H NMR (400MHz, CDCl 3)δ: 0.83(d, 3H, J=6.8Hz, CH 3 ), 1.27(d, 3H, J=6.3Hz, CH 3 ), 2.83~2.92(m, 1H, CH), 5.37(d, 1H, J=9.1Hz, CH), 7.35(d, 2H, J=8.4Hz, ArH), 7.62(d, 2H, J=8.4 Hz, ArH), 7.64(s, 1H, =CH).

[0024] (2) With Z-2-[5-(4-bromobenzylidene)-4-oxo-2-thio-thiazolidin-3-yl]-3-methylbutanoic acid and 5-p-hydroxybenzene Base-1,2-dithiole-3-thione was used as the raw material, and the preparation process was the same as step (2) of Example 1 to obtain a red solid with a yield of 73.4% and a melting point of 159.5~160.7°C. Product Z-2-[5-(4-bromobenzylidene)-4-oxo-2-thio-thiazolidin-3-y...

Embodiment 3

[0027] Using p-chlorobenzaldehyde and 2-(4-oxo-2-thio-thiazolidin-3-yl)-3-methylbutanoic acid as raw materials, the preparation process is the same as step (1) of Example 1 to obtain light Yellow solid, yield 80.3%, melting point 152.0~154.3°C. The hydrogen spectrum of the product Z-2-[5-(4-chlorobenzylidene)-4-oxo-2-thio-thiazolidin-3-yl]-3-methylbutanoic acid 1 H NMR (400MHz, CDCl 3 )δ: 0.87(d, 3H, J=6.6Hz, CH 3 ), 1.26(d, 3H, J=6.9Hz, CH 3 ), 2.84~ 2.93(m, 1H, CH), 5.37(d, 1H, J=9.0Hz, CH), 7.41~7.47(m, 4H, ArH), 7.66(s, 1H, =CH).

[0028] With Z-2-[5-(4-chlorobenzylidene)-4-oxo-2-thio-thiazolidin-3-yl]-4-methylbutanoic acid and 5-p-hydroxyphenyl-1 , 2-dithiole-3-thione was used as the raw material, and the preparation process was the same as step (2) of Example 1 to obtain a red solid with a yield of 70.1% and a melting point of 164.3~165.2°C. Product Z-2-[5-(4-chlorobenzylidene)-4-oxo-2-thioketothiazolidin-3-yl]-4-methylbutanoic acid 4-(3H-1,2-di Thiol-3-thiol-5-yl)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a rhodanine derivative and a preparation method thereof, wherein the structure of the rhodanine derivative is shown in the specification; the preparation method comprises the following steps of: mixing a first rhodanine derivative of Bc1-2 inhibitor with an anti-tumour effect, 5-p-hydroxyphenyl-1,2-benzodithiole-3-thioketone, a condensing agent and alkali in a solvent according to the mass ratio of 1:(1-2):(1-2):0.001:0.1, reacting at 25-100 DEG C for 0.5-24 hours, and purifying, thereby obtaining the rhodanine derivative, wherein X comprises one of F, Br, Cl and Ph; R comprises one of CH2Ph, CH2CH(CH3)2 and CH(CH3)2; and the invention further relates to an anti-tumour drug composed of the rhodanine derivative and pharmaceutically acceptable carriers. By means of the manner, the prepared rhodanine derivative contains pharmacodynamic groups capable of releasing gas signal molecule hydrogen sulphide, is capable of generating anti-tumour synergistic effect, and has good inhibition effect on tumour cells; furthermore, the anti-tumour activity of the rhodanine derivative disclosed by the invention is stronger than that of the first rhodanine derivative before being modified.

Description

technical field [0001] The invention relates to the field of antitumor drugs, in particular to a rhodanine derivative and a preparation method thereof. Background technique [0002] Malignant tumors are one of the most threatening diseases to human beings. The annual global cancer death toll is about 7 million, 24% of which occur in China. At the same time, the cancer mortality rate in my country has been continuously increasing, but the survival rate of cancer patients in China and the cure The number of patients is only 13%, and cancer has become the number one killer that seriously threatens the health of our people. At present, the lesion and metastasis of cancer cells and the mechanism of action of drugs on cancer cells are still unclear, so the current treatment of tumors is still largely based on chemotherapy of anti-tumor drugs. However, chemical drugs have serious side effects and multi-drug resistance, which are always the biggest obstacles for human beings to defe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D417/12A61K31/427A61P35/00
Inventor 敖桂珍楚小晶宋恒刘金宜王盼盼
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap